<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR58">
 <label>58.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Morgensztern</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Herbst</surname>
    <given-names>RS</given-names>
   </name>
  </person-group>
  <article-title>Nivolumab and Pembrolizumab for Non-Small Cell Lung Cancer</article-title>
  <source>Clin Cancer Res</source>
  <year>2016</year>
  <volume>22</volume>
  <fpage>3713</fpage>
  <lpage>3717</lpage>
  <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-15-2998</pub-id>
  <?supplied-pmid 27252413?>
  <pub-id pub-id-type="pmid">27252413</pub-id>
 </element-citation>
</ref>
